First molecular characterization of Cryptosporidium in Yemen by Alyousefi, N.A. et al.
First molecular characterization ofCryptosporidium in Yemen
N. A. ALYOUSEFI1, M. A. K. MAHDY1,2*, Y. A. L. LIM1, L. XIAO3 and R. MAHMUD1
1Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur,Malaysia
2Department of Parasitology, Faculty of Medicine, Sana’a University, Sana’a, Yemen
3Division of Foodborne,Waterborne and Environmental Diseases, National Center for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
(Received 4 August 2012; revised 23 September and 10 October 2012; accepted 15 October 2012; first published online 1 February 2013)
SUMMARY
Cryptosporidium is a protozoan parasite of humans and animals and has a worldwide distribution. The parasite has a unique
epidemiology in Middle Eastern countries where the IId subtype family of Cryptosporidium parvum dominates. However,
there has been no information on Cryptosporidium species in Yemen. Thus, this study was conducted in Yemen to examine
the distribution of Cryptosporidium species and subtype families. Fecal samples were collected from 335 patients who
attended hospitals in Sana’a city.Cryptosporidium species were determined by PCR and sequence analysis of the 18 s rRNA
gene. Cryptosporidium parvum and C. hominis subtypes were identiﬁed based on sequence analysis of the 60 kDa
glycoprotein (gp60) gene. Out of 335 samples, 33 (9·9%) were positive forCryptosporidium. Of them, 97% were identiﬁed as
C. parvum whilst 1 case (3%) was caused by C. hominis. All 7 C. parvum isolates subtyped belonged to the IIaA15G2R1
subtype. The common occurrence of the zoonotic IIa subtype family of C. parvum highlights the potential occurrence of
zoonotic transmission of cryptosporidiosis in Yemen. However, this postulation needs conﬁrmation with future molecular
epidemiological studies of cryptosporidiosis in both humans and animals in Yemen.
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INTRODUCTION
Cryptosporidium is a protozoan parasite in humans
and animals and has a worldwide distribution.
Cryptosporidium infection has been implicated as a
cause of multiple waterborne and foodborne out-
breaks of diarrhoea (MacKenzie et al. 1994; Fayer
et al. 2000; Slifko et al. 2000). Humans can also
acquire the infection through direct contact with
humans (anthroponotic transmission) or animals
(zoonotic transmission). Although cryptosporidiosis
causes self-limiting diarrhoea in immunocompetent
persons, it may lead to life-threatening diarrhoea in
immunocompromised patients (DuPont et al. 1995;
Kjos et al. 2005). The disease has also been
considered as a predictor of malnutrition in early
childhood (Huang and White, 2006).
The genus Cryptosporidium is a multispecies
complex. To date, approximately 27 species and
more than 60 genotypes have been identiﬁed (Fayer
and Santin, 2009; Fayer, 2010; Traversa, 2010; Elwin
et al. 2012). Most of the species or genotypes infect a
particular host with a few notable exceptions.
Cryptosporidium parvum infects humans and several
species of animals, and is the major species respon-
sible for zoonotic cryptosporidiosis in many devel-
oped countries. Another species, C. hominis,
commonly infects humans and is responsible for
anthroponotic transmission, with high prevalence
in developing countries compared with industrial
nations (Raccurt, 2007; Xiao, 2009). Subtyping of
C. parvum based on 60 kDa glycoprotein (gp60) gene
identiﬁed at least 12 subtype families (IIa – IIl). The
zoonotic IIa subtype is predominant in developed
nations and rarely isolated fromhumans indeveloping
nations where the anthroponotic IIc subtype family is
the most common cause of human C. parvum infec-
tions. The C. parvum IIa subtype family has a high
genetic diversity with IIaA15G2R1 being predomi-
nant in calves and the major subtype infecting human
and cattle in some countries (Xiao, 2009, 2010).
The epidemiology of Cryptosporidium in Middle
Eastern countries is diﬀerent from other developing
countries as earlier studies reported that C. parvum
had higher prevalence than C. hominis in Saudi
Arabia (Al-Brikan et al. 2008), Kuwait (Sulaiman
et al. 2005), Jordan (Hijjawi et al. 2010), Turkey
(Tamer et al. 2007), and Iran (Nazemalhosseini-
Mojarad et al. 2011). However, in nearby Egypt,
C. hominis was more prevalent than C. parvum (Eida
et al. 2009; Abd El Kader et al. 2011). Subtype
analysis based on gp60 has shown that the IId subtype
family is the predominant subtype inMiddle Eastern
countries whereas the IIc subtype family is the
dominant C. parvum in developing countries (Xiao,
2010).
In Yemen, cryptosporidiosis is an endemic disease
with prevalence ranging from 1% to 50% (Al-Shibani
et al. 2009; Al-Shamiri et al. 2010; Alyouseﬁ et al.
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2011). Currently, there are no data on Cryptospor-
idium species and subtype families in Yemen. This
study aims at identifyingCryptosporidium species and
subtype families prevalent in Yemen, a poorer
Middle Eastern country. Findings generated from
this study will improve our understanding of
molecular epidemiology of cryptosporidiosis not
only in a developing country like Yemen but also in
the larger Middle Eastern region.
MATERIALS AND METHODS
Sample collection
Fecal samples were collected during December 2008
to March 2009 from 3 main hospitals in Sana’a City,
the capital of Yemen, including the Al-Jomhury
Hospital, Al-Kuwait Hospital and Alzahrawy
Clinical Center. Participation in the study was
voluntary and each participant was asked to provide
informed consent after a brief explanation of the
research objectives by an attending physician or
nurse. If the patient was a child, written informed
consent was obtained from his/her parents.
Permission was also obtained from the authorities
of each hospital. The study protocol was approved by
the Research and Ethical Committee of the Faculty of
Medicine, University of Malaya, Malaysia (MEC
RF.No: 782.9). Fecal samples were collected from all
those who attended the outpatients clinics in hospi-
tals, referred to the laboratory for fecal examination,
and consent to participation in the study. Fecal
specimens were collected in wide-mouthed screw-
capped containers, mixed with 2·5% potassium
dichromate, and stored at 4 °C until DNA extraction.
The minimum sample size required for this study
was 246 individuals. The expected sample size was
calculated according to the following parameters –
expected prevalence of Cryptosporidium at 20%
(Al-Shibani et al. 2009), conﬁdence level at 95%,
and absolute precision at 0·05 (Lwanga and
Lemeshow, 1991). However, 335 individuals were
eventually included.
Questionnaire
Collection of samples was done simultaneously with
data gathering via a pre-tested questionnaire, which
included socio-demographical information such as
age, gender and general area of residence, health
practices, behavioural habits (i.e. washing hands
before eating, washing hands after defecation, and
washing fruits and vegetables), and health conditions
including the occurrence and history of symptoms
(e.g. diarrhoea, nausea, vomiting and abdominal
pain). Environmental factors such as water supply
and direct contact with animals were also included.
The age of participants was categorized into 2
groups: 412 years and >12 years. Detection of
Cryptosporidium in this study was by PCR since this
approach was shown to have higher sensitivity than
modiﬁed Ziehl-Neelsens stain (Starke et al. 2011).
DNA extraction
Fecal samples were washed by centrifugation with
distilled water to remove potassium dichromate used
in fecal storage. DNA was extracted directly from
approximately 0·25 g of fecal samples using the
PowerSoil® DNA Isolation Kit (MO BIO
Laboratories, USA) and the manufacturer’s rec-
ommended procedures. DNA was eluted in 50 μl of
elution buﬀer and kept in the freezer at −20 °C until
use.
Cryptosporidium genotyping
A partial polymorphic region of 18 s rRNA gene
was ampliﬁed according to Nichols et al. (2003).
In the primary reaction, a 655 to 667 bp fragment
was ampliﬁed depending on the species of
Cryptosporidium or C. parvum genotype, using a 27-
mer forward primer (N-DIAGF; 5′-CAA TTG
GAG GGC AAG TCT GGT GCC AGC-3′) and a
26-mer reverse primer (N-DIAGR2; 5′-CCT TCC
TAT GTC TGG ACC TGG TGA GT-3′). The
secondary PCR ampliﬁed a 435 bp fragment using
the forward primer (CPB-DIAGF; 5′-AAG CTC
GTA GTT GGA TTT CTG-3′) and the reverse
primer (CPB-DIAGR; 5′-TAA GGT GCT GAA
GGAGTAAGG-3′) that were previously developed
by Johnson et al. (1995). The primary and the
secondary PCRs were run in a total volume of 50 μL
containing 200 μM of each of the 4 deoxynucleoside
triphosphates (dNTP) (Fermentas, Ontario,
Canada), 0·2 μM of each primer, 400 μgmL−1 of
non-acetylated bovine serum albumin (New England
Biolabs, Ipswich, USA), 3·5 mM of MgCl2
(Fermentas, Ontario, Canada), 2·5 U of Taq poly-
merase (New England Biolabs, Ipswich, USA) and
1× ThermoPol PCR buﬀer (New England Biolabs,
Ipswich, USA). Two μL of DNA template were used
in the primary PCR whereas 5 μL of the primary
PCR product was used as template in the secondary
PCR. The cycling conditions were as follows: hot
start at 95 °C for 5min followed by 35 cycles of
denaturing at 94 °C for 30 s, annealing at 60 °C for
1min and extension at 72 °C for 30 s, and a ﬁnal
extension was at 72 °C for 10min. The secondary
PCR had similar cycling conditions except that
the annealing temperature in the secondary PCR
was 68 °C instead of 60 °C. To minimize cross-
contamination, DNA extraction, PCR reaction and
post-PCRmanipulation were performed in 3 separate
laboratory areas using 3 separate sets of micropipettes
and tips.GenomicDNApositive forCryptosporidium
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was used as the positive control in each run of PCR.
Distilled water was used as the negative control.
Cryptosporidium subtyping
A nested-PCR was used to amplify the partial gp60
gene (Strong et al. 2000; Mallon et al. 2003). In the
primary PCR, a fragment of *980–1000 bp was
ampliﬁed using primers gp15-ATG and gp15-
STOP. Subsequently, a *450 bp fragment was
ampliﬁed in the secondary PCR using the primers
gp15-15A and gp15-15E. The primary and the
secondary PCRs were done in a total volume of
50 μL containing 200 μM of each of the 4 dNTP
(Fermantas), 0·4 μMof each primer, 3 mM of MgCl2
(Fermentas), 2·5 U ofTaq polymerase (NewEngland
Biolabs), and 1× ThermoPol PCR buﬀer (New
England Biolabs). Two μL of DNA template were
used in the primary PCRwhereas 5 μL of the primary
PCR product was used as the template in the
secondary PCR. The cycling conditions were as
follows: hot start at 94 °C for 5min, followed by 40
cycles of denaturing for 30 s at 94 °C, annealing for
45 s at 55 °C and extension for 1min at 72 °C, and a
ﬁnal extension at 72 °C for 10min. The secondary
PCR had 35 cycle conditions with annealing and
extension times for 30 s for each 1 instead of 45 s and
1min, respectively. The PCR products were resolved
on 2% agarose gel and stained with Sybr Safe
(Invitrogen, USA) for both 18S rRNA and gp60
PCR products.
DNA sequencing and subtype determination
PCR products were puriﬁed using the QIAquick Gel
Extraction Kit (QIAgen, Germany), according to the
manufacturer’s instructions, and sequenced in both
directions using the secondary PCR primers. The
sequencing was carried out in an automated DNA
sequencer (3130x1 Genetic Analyzer, Applied
Biosystems, USA) using the BigDye Terminator
v3.1 Cycle sequencing Kit. Sequences were edited
and the consensus sequences were created using
BioEdit software (http://www.mbio.ncsu.edu/bio-
edit/bioedit.html). The consensus sequences were
aligned with reference sequences downloaded from
the GenBank database using ClustalX (http://www.
clustal.org/).Cryptosporidium parvum andC. hominis
gp60 subtypes were named by counting the number
of the trinucleotide repeats of TCA (A), TCG (G)
and TCT (T) and the ACATCA repeat (R) after the
trinucleotide repeats as described previously
(Sulaiman et al. 2005). DNA sequences from this
study were deposited in the GenBank database under
Accession numbers JX032678–JX032693.
Statistical analysis
Data were analysed using the SPSS program for
Window version 11.5 (SPSS Inc. Chicago, IL,
USA). Chi-square test was used to assess the as-
sociation between dependent and independent vari-
ables and 95% conﬁdence intervals were calculated.
Fisher exact test was used where applicable.
Signiﬁcance of the diﬀerence was deﬁned as P<0·05.
RESULTS
Among the 335 study participants, 42% were males
and 58% were females. The age of patients ranged
from 1 to 80 years with a median of 22 years. The 18 s
rRNA-based nested PCR detected Cryptosporidium
in 33 (9·9%) of the 335 patients. Females had a
slightly higher infection rate ofCryptosporidium than
males (10·4% vs 9·3%). A higher prevalence of
cryptosporidiosis was seen in patients who had a
bath at least twice a week (14%) compared with those
who had a bath less than twice a week (8·5%). Patients
who drank untreated water had a higher infection rate
(10·7%) than patients who use treated drinking water
(8·7%). However, these diﬀerences were not signiﬁ-
cant. The result of the statistical analysis is shown
in Table 1.
The 18 s rRNA PCR products of all 33 positive
samples were successfully sequenced. All except
1 (97%) were identiﬁed as C. parvum; the remaining
1 (3%) was identiﬁed as C. hominis. All samples
positive for Cryptosporidium parvum/hominis (33
samples) were subjected to PCR ampliﬁcation target-
ing the partial sequence of the gp60 gene. Of these, 21
samples produced PCR amplicons, which were
sequenced in both directions. The partial sequence
of gp60 gene was successfully sequenced for 7 isolates
of C. parvum and the isolate of C. hominis. Sequence
analysis of the gp60 gene identiﬁed all 7 C. parvum
isolates as the IIaA15G2R1 subtype of the IIa
subtype family. Compared with sequences deposited
in the GenBank database, the sequence of the IIa
subtype family from this study matched the
IIaA15G2R1 subtype from a human in Australia
(GenBank Accession no. JF727795) (Waldron et al.
2011) the UK (GenBank accession no. HQ149037)
(Hadﬁeld et al. 2011) and Iran (GenBank Accession
no. AB560747) (Nazemalhosseini-Mojarad et al.
2011). The C. hominis isolate was identiﬁed as the
IeA11G3T3 subtype of the Ie subtype family which
matched gp60 gene sequence of the IeA11G3T3
subtype of the Ie subtype family isolated from
humans in the UK (GenBank Accession no.
GU214354) (Pangasa et al. 2010) and Canada
(GeneBank Accession no. DQ192509) (Trotz-
Williams et al. 2006).
DISCUSSION
In the current study the prevalence of
Cryptosporidium was 9·9% by PCR, which is 10
times higher than our previous report based on the
microscopical examination of fecal smears stained
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with Ziehl–Neelsen stain (Alyouseﬁ et al. 2011).
This diﬀerence could be attributed to the higher
sensitivity of PCR. The superiority of PCR
compared with microscopy was previously reported
(Johnson et al. 1995; Stark et al. 2011). In addition, it
was demonstrated that the threshold of the 100%
sensitivity of Ziehl–Neelsen staining technique
is 500000 oocysts per gram of feces (Weber et al.
1991).
This study is the ﬁrst report of Cryptosporidium
species and subtypes in Yemen. The current results
showed that all isolates were C. parvum except 1
isolate, which was identiﬁed as C. hominis. These
ﬁndings are consistent with previous reports in other
Middle Eastern countries (Sulaiman et al. 2005;
Tamer et al. 2007; Al-Brikan et al. 2008; Hijjawi et al.
2010; Xiao, 2010; Nazemalhosseini-Mojarad et al.
2011). In Saudi Arabia, a neighbouring country of
Yemen, of the 31 human fecal samples examined,
Al-Brikan and his colleagues detected C. parvum and
C. hominis in 15 and 13 samples, respectively
(Al-Brikan et al. 2008). Subsequently, in the same
country, another study found C. parvum in 43 of 53
samples examined (Nazemalhosseini-Mojarad et al.
2012). Similar results have also been reported in
Kuwait where C. parvum was the predominant
causative agent for cryptosporidiosis in children
(Sulaiman et al. 2005; Iqbal et al. 2011). A molecular
epidemiological study conducted in Jordan identiﬁed
C. parvum and C. hominis in 22 and 20 specimens,
respectively (Hijjawi et al. 2010). In Iran, collective
data generated from 4 molecular epidemiological
studies showed a predominance of C. parvum
(Nazemalhosseini-Mojarad et al. 2012). In contrast,
2 molecular epidemiological studies reported the
presence of C. parvum and C. hominis in Egypt with
the predominance of C. hominis (Abd El Kader et al.
2012). It has been reported thatC. hominis is the most
common species in developing countries with the
common occurrence of Ia, Ib, Id and Ie subtype
families. In Europe and Australia, and North
America, the IIa subtype family is the dominant
C. parvum, suggesting zoonotic transmission of
Cryptosporidium may be common in these countries.
Although C. parvum is prevalent in some developing
countries, the anthroponotic IIc subtype family is the
most common subtype family of C. parvum in
humans in these countries (Xiao, 2010).
Table 1. Prevalence and distribution of Cryptosporidium in patients seeking healthcare in Sana’a City
(The level of signiﬁcance was deﬁned as P<0·05. The sum of some variables are not always 335 due to missing data.)
Variables No. examined No. positive (%) OR (95%CI) P value
Demographic
Age (years) >12 233 24 (10·3) 1 0·68
412 102 9 (8·80) 0·84 (0·38–1·88)
Address Urban 242 25 (10·3) 1 0·70
Rural 90 8 (8·90) 0·85 (0·37–1·95)
Gender Male 151 14 (9·30) 1 0·74
Female 183 19 (10·4) 1·13 (0·55–2·35)
Household members <5 94 9 (9·60) 1 0·92
55 241 24 (10·0) 1·05 (0·47–2·34)
Personal hygiene
Washing hands after defecation Yes 151 15 (9·90) 1 0·85
No 172 16 (9·30) 0·93 (0·44–1·95)
Washing hands before eating Yes 137 16 (11·7) 1 0·41
No 191 17 (8·90) 0·74 (0·36–1·52)
Washing fruits and vegetables Yes 253 25 (9·90) 1 0·87
No 76 8 (10·5) 1·07 (0·46–2·49)
Type of drinking water Treated 126 11 (8·7) 1 0·57
Not treated 206 22 (10·7) 1·25 (0·58–2·67)
Bathing twice or more weekly Yes 248 21 (8·50) 1 0·13
No 85 12 (14·1) 1·78 (0·83–3·79)
Rearing animalsa No 238 23 (9·70) 1 0·84
Yes 96 10 (10·4) 1·09 (0·49–2·38)
Clinical symptoms
Diarrhoea# No 225 20 (8·90) 1 0·37
Yes 108 13 (12·0) 1·40 (0·67–2·94)
Other symptoms* No 40 3 (7·5) 1 0·78
Yes 294 30 (10·2) 1·40 (0·41–4·8)
a Rearing animals was deﬁned as the traditional rearing which involves sending animals tomountains and valleys for grazing
and caring of animals in shelters within the house vicinity.
# Diarrhoea was deﬁned as loose stools for 3 consecutive times/day.
* Other symptoms included vomiting, abdominal pain and/or nausea, Fisher exact test was used for calculating the
signiﬁcance in this variable.
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It is our understanding that geographical distri-
bution of Cryptosporidium species is not a conclusive
indication of diﬀerences in the transmission of
cryptosporidiosis. Although C. parvum has been
known as a zoonotic species, most subtype families
ofC. parvum identiﬁed (IIb, IIc, IIe – IIl) in humans
are probably not zoonotic in origin (Xiao, 2010). In
this study, all C. parvum subtyped belonged to
IIaA15G2R1 subtype of the IIa subtype family.
The subtype IIaA15G2R1 is the major subtype of
C. parvum in cattle in developed countries (Alves
et al. 2003; Wu et al. 2003; Sulaiman et al. 2005; Abe
et al. 2006; Cohen et al. 2006; Trotz-Williams et al.
2006; Feng et al. 2007; Thompson et al. 2007; Broglia
et al. 2008; Wielinga et al. 2008). This subtype has
also been found in humans in the USA (Santin et al.
2008), Canada (Budu-Amoako et al. 2012), the UK
(Chalmers et al. 2009), the Netherlands (Wielinga
et al. 2008), Slovenia (Soba and Logar, 2008),
Portugal (Alves et al. 2006), Ireland (Thompson
et al. 2007), Japan (Abe et al. 2006), Australia (Ng
et al. 2008), and Malaysia (Iqbal et al. 2012).
However, it has been rarely reported in humans in
developing countries, where most C. parvum infec-
tions are caused by the anthroponotic IIc subtype
family (Xiao, 2010).
In Middle Eastern countries, the subtype family
IIa is responsible for some C. parvum infections in
humans. Itwas reported in 7 of 22C. parvum-infected
patients from Iran (Nazemalhosseini Mojarad et al.
2010), 3 of 13 patients from Jordan (Hijjawi et al.
2010), and 1 of 37 patients from Saudi Arabia
(Nazemalhosseini-Mojarad et al. 2012). Another zoo-
notic C. parvum subtype family, IId, is also common
in humans in this region (Nazemalhosseini-Mojarad
et al. 2012). The predominance of the zoonotic
subtype families of C. parvum IIa and IId in the
Middle Eastern regions suggests that animal-to-
human transmission may be a common transmission
route of Cryptosporidium. However, this postulation
may be premature in view of ﬁndings in 2 studies
conducted in Kuwait (Sulaiman et al. 2005; Iqbal
et al. 2011) where there was no contact with farm
animals by most of the study participants and
desalinated seawater was the source of drinking
water in the study area. As contact with animals in
the context of illness course is a key requirement to
document the occurrence of the zoonotic trans-
mission, the authors suggested that the source of
C. parvum infection in Kuwait was from humans.
In Yemen, the situation is diﬀerent from other
Middle Eastern countries whereby people in Yemen
have very close contact with animals, especially in
the rural and suburban areas. It is a very common
practice to keep animals inside or next to houses
rather than on farms. In addition, local veterinarian
services are also limited, thus local or imported
animals are not routinely screened for parasitic
diseases. These circumstances provide a suitable
environment for the transmission of zoonotic dis-
eases. Thus, the fact that all C. parvum isolates
successfully subtyped belong to the IIa subtype
family may represent potential evidence for the
possible zoonotic transmission of Cryptosporidium
in Yemen. However, the small number of the
C. parvum isolates subtyped has limited the strength
of this conclusion, and more conclusive evidence
should come from case-controlled studies and geno-
typing/subtyping of Cryptosporidium spp. from hu-
mans and animals in the same household or locality.
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